Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Olle, Werlenius"'
Autor:
Kristoffer Hellstrand, Fredrik B. Thorén, Anna Martner, Johan Aurelius, Olle Werlenius, Ebru Aydin, Roberta Kiffin, Alexander Hallner, Ali A. Akhiani
The phosphatidylinositol-4,5-bisphosphate-3 kinase-δ (PI3Kδ) inhibitor idelalisib, used alone or in combination with anti-CD20, is clinically efficacious in B-cell lymphoma and chronic lymphocytic leukemia (CLL) by promoting apoptosis of malignant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d64c16e9eaf6192071104d27b919a54
https://doi.org/10.1158/2326-6066.c.6550396
https://doi.org/10.1158/2326-6066.c.6550396
Autor:
Kristoffer Hellstrand, Fredrik B. Thorén, Anna Martner, Johan Aurelius, Olle Werlenius, Ebru Aydin, Roberta Kiffin, Alexander Hallner, Ali A. Akhiani
Supplementary Figures and Table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35c3cb2189d962dd425e7fd4e3e3c6d
https://doi.org/10.1158/2326-6066.22543753.v1
https://doi.org/10.1158/2326-6066.22543753.v1
Autor:
Eileen Wedge, Peter Rohon, Ingunn Dybedal, Kirsten Grønbæk, Mette Holm, Lone Smidstrup Friis, Astrid Olsnes Kittang, Johanna Ungerstedt, Eva Hellström-Lindberg, Peter Antunovic, Elsa Bernard, Elisabeth Ejerblad, Lennart Nilsson, Martin Jädersten, Mette K. Andersen, Olle Werlenius, Elli Papaemmanuil, Per Ljungman, Fryderyk Lorenz, Jakob Werner Hansen, Maria Creignou
Publikováno v:
Wedge, E, Hansen, J W, Dybedal, I, Creignou, M, Ejerblad, E, Lorenz, F, Werlenius, O, Ungerstedt, J, Holm, M S, Nilsson, L, Kittang, A O, Antunovic, P, Rohon, P, Andersen, M K, Papaemmanuil, E, Bernard, E, Jädersten, M, Hellström-Lindberg, E, Grønbæk, K, Ljungman, P & Friis, L S 2021, ' Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia : Clinical and Molecular Genetic Prognostic Factors in a Nordic Population ', Transplantation and Cellular Therapy, vol. 27, no. 12, pp. 991.e1-991.e9 . https://doi.org/10.1016/j.jtct.2021.08.028
Chronic myelomonocytic leukemia (CMML) is an aggressive disease in which survival after allogeneic hematopoietic stem cell transplantation (HCT) remains relatively poor. An assessment of prognostic factors is an important part of treatment decision m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee793f8cc76cd3a62147409897774bda
https://pure.au.dk/portal/da/publications/allogeneic-hematopoietic-stem-cell-transplantation-for-chronic-myelomonocytic-leukemia(b7a117f6-22cb-4efb-a48a-cbdd3ceeca4f).html
https://pure.au.dk/portal/da/publications/allogeneic-hematopoietic-stem-cell-transplantation-for-chronic-myelomonocytic-leukemia(b7a117f6-22cb-4efb-a48a-cbdd3ceeca4f).html
Autor:
Ali A Akhiani, Olle Werlenius, Johan Aurelius, Charlotta Movitz, Anna Martner, Kristoffer Hellstrand, Fredrik B Thorén
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89646 (2014)
Reactive oxygen species (ROS) are formed by myeloid cells as a defense strategy against microorganisms. ROS however also trigger poly(ADP-ribose) polymerase 1- (PARP-1) dependent cell death (parthanatos) in adjacent lymphocytes, which has been forwar
Externí odkaz:
https://doaj.org/article/b6254d98dcb94cf3a55d4ecbcdad9a7a
Autor:
Daniel Olsson, Sten Eirik W. Jacobsen, Kirsten Groenbaek, Soili Kytölä, Duruta Weber, Magnus Tobiasson, Jörg Cammenga, Lone Smidstrup Friis, Tatjana Pandzic, Lennart Nilsson, Ingunn Dybedal, Johanna Illman, Simone Weström, Lucia Cavelier, Eva Hellstrom Lindberg, Olle Werlenius, Fryderyk Lorentz, Astrid Olsnes Kittang, Freja Ebeling, Stephan Mielke, Bengt Rasmussen, Gitte Olesen, Elisabeth Ejerblad, Gunilla Walldin, Andreas T. Björklund, Marios Dimitriou
Publikováno v:
Tobiasson, M, Pandzic, T, Illmann, J, Nilsson, L, Weström, S, Olsson, D, Ejerblad, E, Olsnes Kittang, A, Olesen, G, Werlenius, O, Björklund, A T, Lorentz, F, Rasmussen, B E H, Cammenga, J, Dimitriou, M D, Kytölä, S, Walldin, G, Groenbaek, K, Mielke, S, Waelgaard Jacobsen, S E, beling, F, Cavelier, L, Friis, L S, Dybedal, I, Hellström-Lindberg, E & Weber, D 2020, ' Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers : The Prospective Nordic Study NMDSG14B ', Blood, vol. 136, no. Suppl. 1, pp. 5-6 . https://doi.org/10.1182/blood-2020-138782
Introduction One third of patients with myelodysplastic syndrome (MDS) will relapse after allogeneic stem cell transplantation (SCT), with a dismal prognosis. Early detection of relapse enables pre-emptive treatment and may potentially reduce relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cf759f79d27be0d17a7972a7caeeaac
https://portal.findresearcher.sdu.dk/da/publications/1987205d-9146-40f1-b5e1-94cb7b1cd006
https://portal.findresearcher.sdu.dk/da/publications/1987205d-9146-40f1-b5e1-94cb7b1cd006
Autor:
Roberta Kiffin, Ebru Aydin, Olle Werlenius, Kristoffer Hellstrand, Ali A. Akhiani, Alexander Hallner, Johan Aurelius, Anna Martner, Fredrik B. Thorén
Publikováno v:
Cancer immunology research. 8(12)
The phosphatidylinositol-4,5-bisphosphate-3 kinase-δ (PI3Kδ) inhibitor idelalisib, used alone or in combination with anti-CD20, is clinically efficacious in B-cell lymphoma and chronic lymphocytic leukemia (CLL) by promoting apoptosis of malignant
Autor:
Kristoffer Hellstrand, Rebecca E. Riise, Anna Martner, Olle Werlenius, Alexander Hallner, Fredrik B. Thorén, Lars Möllgård, Johan Aurelius, Markus Hansson, Mats Brune
Publikováno v:
Journal of Leukocyte Biology. 102:459-466
Chronic myelomonocytic leukemia (CMML) is a myeloproliferative and myelodysplastic neoplasm with few treatment options and dismal prognosis. The role of natural killer (NK) cells and other antileukemic lymphocytes in CMML is largely unknown. We aimed
Autor:
Kristoffer Hellstrand, Maria Simpanen, Olle Werlenius, Per-Ola Andersson, Ali A. Akhiani, Alexander Hallner, Johan Aurelius, Anna Martner, Fredrik B. Thorén
Publikováno v:
Oncotarget
// Olle Werlenius 1,2 , Johan Aurelius 1,2 , Alexander Hallner 2 , Ali A. Akhiani 2 , Maria Simpanen 2 , Anna Martner 2 , Per-Ola Andersson 3 , Kristoffer Hellstrand 2 and Fredrik B. Thoren 2 1 Department of Hematology, Sahlgrenska University Hospita
Publikováno v:
Scandinavian Journal of Immunology. 79:415-422
Antigen-loaded dendritic cells (DCs) used as anticancer vaccine holds promise for therapy, but needs to be optimized. The most frequently described DC vaccine is being matured with a cocktail containing prostaglandin E2 (PGE2 DC). However, even thoug
Autor:
Olle, Werlenius
Reactive oxygen species (ROS) are produced by myeloid cells as a mechanism of defense against infection, but also to resolve inflammation, as ROS can induce cell death in T cells and NK cells. ROS production may also be deployed as a mechanism by whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1149::f5c51b9ecddb58908612a22ded98a48b